Remi Bader discusses her health journey candidly.
In 2020, the TikTok star opened up about her experience with Ozempic and how it affected her overall health. The drug was prescribed to her because she was pre-diabetic and insulin-resistant.
During the Jan. 12 episode of Dear Media’s Not Skinny But Not Fat podcast, Remi recalled, “It was brand new, just got approved by the FDA, no one knew about it, and I was so scared.” I need this, they said. I also had a lot of mixed emotions.”
However, Remi stopped using the drug a few months later, which led to a cycle of “bad binging.”
The 27-year-old went on to say, “I saw a doctor, and they were like, “It’s 100 percent because you went on Ozempic.” For so long, it was making me believe I wasn’t hungry. I’ve shed some pounds. I didn’t want to obsess over staying on it for a long time. I thought, “I bet the second I got off I’m going to get hungry again,” and I was right. When I did, my bingeing got even worse. As a result, Ozempic came to my mind.
As a drug that celebrities use to lose weight quickly, Ozempic has made headlines in recent months. However, Remi noted that she actually gained more weight when she stopped taking the medication, despite its negative effects on weight loss.
She disclosed, “I gained double the weight back after.” I disclosed my involvement with it in a single post about it.
Amanda Hirsch, the host, also intervened to express her position regarding the use of the drug for weight loss rather than diabetes following Remi’s remarks.
“It’s all over.” “Said the 34-year-old. I find it upsetting that practically everyone in the world is getting shots that have side effects that could be bad for your health.
When E! Novo Nordisk representatives told News that Ozempic is “not approved for chronic weight management.” According to the brand’s statement, it is designed to treat adults with type 2 diabetes, improve blood sugar levels, and lower the risk of major cardiovascular events.
On January 18, 2023, at 2:00 p.m. PT, the reason Remi Bader was given Ozempic was added to this article.